✦ LIBER ✦

MP-08.21: A multicentre, randomised one year dose-finding study of degarelix, a gonadotrophin-releasing hormone (GnRH) receptor blocker, in prostate cancer patients

✍ Scribed by M. Gittelman; P.J. Pommerville; B.E. Persson; T. Kold Olesen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A ONE-YEAR, MULTICENTRE, RANDOMISED STUD

✍ H. Van Poppel; J. De La Rosette; B.E. Persson; J.K. Jensen; T.K. Olesen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

23 LONG-TERM EVALUATION OF DEGARELIX, A

✍ H. Van Poppel; J.J. De La Rosette; B.E. Persson; T.K. Olesen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Degarelix: A Novel Gonadotropin-Releasin

✍ Hendrik Van Poppel; Bertrand Tombal; Jean J. de la Rosette; Bo-Eric Persson; Jen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 647 KB

Editorial Comment on: Degarelix: a Novel

✍ Patrick J. Bastian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Editorial Comment on: Degarelix: A Novel

✍ Peter Whelan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

EFFICACY AND SAFETY OF TEVERELIX, A NEW

✍ C. Maclean; A. Ulys; F. Jankevičius; D. Kaniušas; J. Drewe; F. Larsen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB